Not all evidence is equal, and in the supplement world the difference matters more than most buyers realise. A claim backed by a large randomised trial is a different thing from a claim backed by a laboratory study on cells, or by traditional use, or by nothing at all. Learning to weigh evidence — to tell what counts, what does not, and how to tell the difference — is the single most useful skill a supplement buyer can develop.
At the top of the hierarchy sits the systematic review: a careful summary of all the studies on a question, including the ones that found no effect. Above individual trials, systematic reviews show what the evidence says as a whole, rather than what a single study happened to find. Below them sit randomised controlled trials, where participants are randomly assigned to receive the ingredient or a placebo, and neither they nor the researchers know who received what. This design controls for placebo effects and for the many other factors that can make people feel better.
Below randomised trials sit weaker designs: open-label pilots with no control group, observational studies that find associations without proving cause, and case reports of individual experiences. These can suggest directions for further research, but they cannot prove a product works. Below them again sit laboratory studies — on cells, or in animals — which may be interesting, but which do not show that the same effect occurs in people. And at the bottom sits traditional use: the fact that a plant has been used for centuries tells you it has a history, not that it works, and not at what dose.
The hierarchy matters because brands rarely respect it. A product may cite a laboratory study as if it were a clinical trial, or a traditional use as if it were evidence, or a single small pilot as if it were proof. The citation looks impressive; the evidence behind it is thin. The buyer's defence is to ask, for each claim, what kind of evidence supports it, and whether that evidence matches the product as sold — the same ingredient, the same form, the same dose, in a comparable population.
Dose is the detail that most often breaks the link between evidence and product. A study that tested an ingredient at 500 mg a day tells you nothing about a product containing 50 mg. A study of a standardised extract tells you nothing about a raw powder. A study in healthy young adults tells you nothing about older adults, or about people with a medical condition. Research is specific, and a claim that ignores that specificity is borrowing authority it has not earned.
Funding matters too. Research paid for by the manufacturer is not automatically wrong, but it carries a higher risk of bias — in the design, in the choice of outcomes, and in whether negative results are published. Independent replication, where a different team with no financial interest reaches the same conclusion, is the strongest evidence available, and it is also the rarest.
Independent reviews can do this weighing for you. Thesupplementrating.com publishes evidence-led reviews that trace claims to the studies behind them, check design, dose and funding, and state their limits plainly — and its safety checklist covers the five checks that matter most before you buy. A review of a slimming tea formula shows the method in practice: the evidence first, the product second, and the verdict last.
Evidence is a tool, not a slogan. Ask what kind it is, check the dose, and let the research — not the citation — decide.
